|
|
| | 2,3,10-trimethoxy-5,8,13,13a-tetrahydro-6H-isoquinolino[3,2-a]isoquinolin-9-yl 3-fluorobenzenesulfonate Basic information |
| Product Name: | 2,3,10-trimethoxy-5,8,13,13a-tetrahydro-6H-isoquinolino[3,2-a]isoquinolin-9-yl 3-fluorobenzenesulfonate | | Synonyms: | Benzenesulfonic acid, 3-fluoro-, 5,8,13,13a-tetrahydro-2,3,10-trimethoxy-6H-dibenzo[a,g]quinolizin-9-yl ester;PCSK9-IN-29 | | CAS: | 1233353-86-0 | | MF: | C26H26FNO6S | | MW: | 499.55 | | EINECS: | | | Product Categories: | | | Mol File: | 1233353-86-0.mol | ![2,3,10-trimethoxy-5,8,13,13a-tetrahydro-6H-isoquinolino[3,2-a]isoquinolin-9-yl 3-fluorobenzenesulfonate Structure](CAS/20210111/GIF/1233353-86-0.gif) |
| | 2,3,10-trimethoxy-5,8,13,13a-tetrahydro-6H-isoquinolino[3,2-a]isoquinolin-9-yl 3-fluorobenzenesulfonate Chemical Properties |
| Boiling point | 641.4±55.0 °C(Predicted) | | density | 1.40±0.1 g/cm3(Predicted) | | pka | 6.15±0.20(Predicted) | | form | Solid | | color | Off-white to light yellow |
| | 2,3,10-trimethoxy-5,8,13,13a-tetrahydro-6H-isoquinolino[3,2-a]isoquinolin-9-yl 3-fluorobenzenesulfonate Usage And Synthesis |
| Uses | PCSK9-IN-29 is a lipid-lowering agent. PCSK9-IN-29 can increase low-density lipoprotein receptor (LDLR) protein expression and decrease PCSK9 protein expression in hepG2 cells. PCSK9-IN-29 can reduce the levels of serum LDL-C, TC, and liver enzyme ALT in crab eating macaques fed a high-fat diet, lower body weight and fat, and increase bone mineral content. PCSK9-IN-29 can be used for research on non-alcoholic fatty liver disease and obesity[1]. | | References | [1] Liu, Jing Wen, et al. Compounds, compositions and methods for treating NASH, NAFLD and obesity. China, CN115279755A. 2022-11-01. |
| | 2,3,10-trimethoxy-5,8,13,13a-tetrahydro-6H-isoquinolino[3,2-a]isoquinolin-9-yl 3-fluorobenzenesulfonate Preparation Products And Raw materials |
|